WGU D116 ADVANCED
PHARMACOLOGY FINAL EXAM
QUESTIONS AND ANSWERS 2026/2027
1. A patient with a high volume of distribution (Vd) for a specific drug would likely require
which of the following to achieve therapeutic plasma concentrations?
A. A lower loading dose
B. A decrease in the infusion rate
C. More frequent dosing intervals
D. A higher loading dose
Answer: D
Conceptual Explanation: Volume of distribution represents the extent to which a drug
distributes into body tissues. A high Vd means the drug leaves the plasma; therefore, a
higher loading dose is needed to reach the target plasma concentration.
2. Which of the following describes the ‘first-pass effect’ in pharmacokinetics?
A. Rapid renal excretion of a drug after the first dose
B. The immediate onset of action seen with IV administration
,C. The initial binding of a drug to plasma albumin
D. Metabolism of a drug in the gut wall or liver before reaching systemic circulation
Answer: D
Conceptual Explanation: The first-pass effect refers to the metabolism of an orally
administered drug in the liver or intestines before it reaches the systemic circulation,
significantly reducing its bioavailability.
3. A patient is prescribed Rifampin for tuberculosis. Rifampin is a known potent inducer of
the CYP3A4 enzyme. If this patient is also taking Warfarin, what is the most likely clinical
outcome?
A. Increased risk of bleeding due to higher Warfarin levels
B. Decreased risk of thrombosis due to synergism
C. Reduced efficacy of Warfarin, requiring an increased dose
D. Development of Vitamin K toxicity
Answer: C
Conceptual Explanation: Enzyme inducers like Rifampin increase the metabolism of
substrate drugs like Warfarin, leading to lower plasma concentrations and reduced
therapeutic effect (lower INR).
, 4. Which receptor subtype is primarily responsible for increasing heart rate and myocardial
contractility when stimulated?
A. Alpha-1 adrenergic
B. Beta-1 adrenergic
C. Beta-2 adrenergic
D. Muscarinic M2
Answer: B
Conceptual Explanation: Beta-1 receptors are predominantly located in the heart. Their
stimulation leads to positive inotropic (contractility) and chronotropic (heart rate) effects.
5. A patient with asthma requires a beta-blocker for the management of hypertension. Which
of the following agents would be the safest choice to avoid bronchoconstriction?
A. Metoprolol
B. Nadolol
C. Propranolol
D. Timolol
Answer: A
Conceptual Explanation: Metoprolol is a cardioselective Beta-1 blocker. Non-selective
beta-blockers like Propranolol can block Beta-2 receptors in the lungs, triggering
bronchospasm in asthmatic patients.
PHARMACOLOGY FINAL EXAM
QUESTIONS AND ANSWERS 2026/2027
1. A patient with a high volume of distribution (Vd) for a specific drug would likely require
which of the following to achieve therapeutic plasma concentrations?
A. A lower loading dose
B. A decrease in the infusion rate
C. More frequent dosing intervals
D. A higher loading dose
Answer: D
Conceptual Explanation: Volume of distribution represents the extent to which a drug
distributes into body tissues. A high Vd means the drug leaves the plasma; therefore, a
higher loading dose is needed to reach the target plasma concentration.
2. Which of the following describes the ‘first-pass effect’ in pharmacokinetics?
A. Rapid renal excretion of a drug after the first dose
B. The immediate onset of action seen with IV administration
,C. The initial binding of a drug to plasma albumin
D. Metabolism of a drug in the gut wall or liver before reaching systemic circulation
Answer: D
Conceptual Explanation: The first-pass effect refers to the metabolism of an orally
administered drug in the liver or intestines before it reaches the systemic circulation,
significantly reducing its bioavailability.
3. A patient is prescribed Rifampin for tuberculosis. Rifampin is a known potent inducer of
the CYP3A4 enzyme. If this patient is also taking Warfarin, what is the most likely clinical
outcome?
A. Increased risk of bleeding due to higher Warfarin levels
B. Decreased risk of thrombosis due to synergism
C. Reduced efficacy of Warfarin, requiring an increased dose
D. Development of Vitamin K toxicity
Answer: C
Conceptual Explanation: Enzyme inducers like Rifampin increase the metabolism of
substrate drugs like Warfarin, leading to lower plasma concentrations and reduced
therapeutic effect (lower INR).
, 4. Which receptor subtype is primarily responsible for increasing heart rate and myocardial
contractility when stimulated?
A. Alpha-1 adrenergic
B. Beta-1 adrenergic
C. Beta-2 adrenergic
D. Muscarinic M2
Answer: B
Conceptual Explanation: Beta-1 receptors are predominantly located in the heart. Their
stimulation leads to positive inotropic (contractility) and chronotropic (heart rate) effects.
5. A patient with asthma requires a beta-blocker for the management of hypertension. Which
of the following agents would be the safest choice to avoid bronchoconstriction?
A. Metoprolol
B. Nadolol
C. Propranolol
D. Timolol
Answer: A
Conceptual Explanation: Metoprolol is a cardioselective Beta-1 blocker. Non-selective
beta-blockers like Propranolol can block Beta-2 receptors in the lungs, triggering
bronchospasm in asthmatic patients.
